123 related articles for article (PubMed ID: 542191)
1. Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin.
Preisler H; Bjornsson S; Henderson ES; Hryniuk W; Higby D; Freeman A; Naeher C
Med Pediatr Oncol; 1979; 7(3):269-75. PubMed ID: 542191
[TBL] [Abstract][Full Text] [Related]
2. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of a combination of intermediate-dose cytosine arabinoside, adriamycin and vincristine in relapsed acute leukemia].
Takahashi I; Yorimitsu S; Inagaki T; Sekito N; Hayashi N; Nishimura M; Aoyama S; Nakada H; Ohmoto E; Uchida K
Gan To Kagaku Ryoho; 1987 Feb; 14(2):485-9. PubMed ID: 3813576
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia.
Slevin ML; Rohatiner AZ; Dhaliwal HS; Henry GP; Bell R; Lister TA
Med Pediatr Oncol; 1982; 10 Suppl 1():185-92. PubMed ID: 6962318
[TBL] [Abstract][Full Text] [Related]
5. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Cassileth PA; Katz ME
Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
Movassaghi N; Higgins G; Pyesmany A; Baehner R; Chard R; Sather H; Hammond D
Med Pediatr Oncol; 1984; 12(5):352-6. PubMed ID: 6208468
[TBL] [Abstract][Full Text] [Related]
8. Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.
Chard RL; Finklestein JZ; Sonley MJ; Nesbit M; McCreadie S; Weiner J; Sather H; Hammond GD
Med Pediatr Oncol; 1978; 4(3):263-73. PubMed ID: 355821
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinoside.
Takahashi I; Hara M; Uchida K; Takaoka K; Watanabe S; Lai M; Hamasaki K; Kohi F; Kitajima K; Kimura I; Adachi T; Yorimitsu S; Tokioka M; Sanada H
Acta Med Okayama; 1982 Feb; 36(1):77-80. PubMed ID: 6950658
[TBL] [Abstract][Full Text] [Related]
10. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
11. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
Grant S; Baker M; Bhalla K
Leukemia; 1993 Dec; 7(12):1933-8. PubMed ID: 8255091
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens.
Preisler HD; Rustum Y; Henderson ES; Bjornsson S; Creaven PJ; Higby DJ; Freeman A; Gailani S; Naeher C
Blood; 1979 Mar; 53(3):455-64. PubMed ID: 760861
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group Study.
Schreiter SL; Amare M; Stuckey WJ; Oishi N; Saiki JH; Vial R; Pendleton O; Morrison FS
Am J Clin Oncol; 1982 Dec; 5(6):641-3. PubMed ID: 7165007
[TBL] [Abstract][Full Text] [Related]
15. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
16. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
17. High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
Garewal H; Durie BG; Greenberg B
Oncology; 1987; 44(6):333-5. PubMed ID: 3684173
[TBL] [Abstract][Full Text] [Related]
18. High-dose cytosine arabinoside for acute nonlymphocytic leukemia.
Cantin G; Brennan JK
Am J Hematol; 1984 Jan; 16(1):59-66. PubMed ID: 6695910
[TBL] [Abstract][Full Text] [Related]
19. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
Vidarsson B; Abonour R; Williams EC; Woodson RD; Turman NJ; Kim K; Mosher DF; Wiersma SR; Longo WL
Leuk Lymphoma; 2001 Apr; 41(3-4):321-31. PubMed ID: 11378544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
